amfAR is one of the world's leading nonprofit organizations dedicated to the support of HIV/AIDS research, HIV prevention, treatment education, and the advocacy of sound AIDS-related public policy. With its freedom and flexibility to respond quickly to emerging opportunities and its determination to invest in cutting-edge science, amfAR plays a unique, catalytic role in accelerating the pace of HIV/AIDS research and achieving real breakthroughs. Funded by voluntary contributions from individuals, foundations, and corporations, amfAR has invested nearly $275 million in support of its mission since 1985 and funded grants to more than 2,000 research teams worldwide.